Cargando…
Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials
BACKGROUND: The objective of this study was to evaluate the safety and efficacy of carbon‐ion radiotherapy (CIRT) in patients with hepatocellular carcinoma (HCC) with stepwise dose escalation and hypofractionation in 2 combined prospective trials. METHODS: Sequential phase 1/2 (protocol 9603) and ph...
Autores principales: | Kasuya, Goro, Kato, Hirotoshi, Yasuda, Shigeo, Tsuji, Hiroshi, Yamada, Shigeru, Haruyama, Yasuo, Kobashi, Gen, Ebner, Daniel K., Okada, Naomi Nagatake, Makishima, Hirokazu, Miyazaki, Masaru, Kamada, Tadashi, Tsujii, Hirohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655922/ https://www.ncbi.nlm.nih.gov/pubmed/28662297 http://dx.doi.org/10.1002/cncr.30816 |
Ejemplares similares
-
Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
por: Yasuda, Shigeo, et al.
Publicado: (2019) -
Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2016) -
Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2017) -
Updated long‐term outcomes after carbon‐ion radiotherapy for primary renal cell carcinoma
por: Kasuya, Goro, et al.
Publicado: (2018) -
Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma
por: Kasuya, Goro, et al.
Publicado: (2019)